roberto conti's Publications List

Selective reversible inhibition of liver carnitine palmitoyl-transferase 1 by teglicar reduces gluconeogenesis and improves glucose homeostasis.

2012-01-24T16:50:25Z

Conti R, Mannucci E, Pessotto P, Tassoni E, Carminati P, Giannessi F, Arduini A. (2011) diabetes 60: 2 644-651

Derivatives of R-aminocarnitine without ammonium moiety as liver carnitine palmitoyltransferase I (L-CPT I) inhibitors

2012-01-24T17:00:58Z

Tassoni E, Conti R, Gallo G, Vincenti S, Mastrofrancesco L, Brunetti T, Cabri W, Giannessi F. (2011) ChemMedChem 6: 11 1977-80

Effects of the increase in neuronal fatty acids availability on food intake and satiety in mice

2012-01-24T17:02:46Z

Coccurello R, Caprioli A, Bellantuono S, D'Amato FR, Conti R, Giannessi F, Borsini F, Moles A. (2010) Psychopharmacology (Berl) 210: 1 85-95

Aminocarnitine ureidic derivatives as inhibitors of carnitine palmitoyltransferase I

2012-01-24T17:00:30Z

Tassoni E, Conti R, Gallo G, Vincenti S, Dell'Uomo N, Mastrofrancesco L, Ricciolini R, Cabri W, Carminati P, Giannessi F. (2010) ChemMedChem 5: 5 666-9

30 days of continuous olanzapine infusion determines energy imbalance, glucose intolerance, insulin resistance, and dyslipidemia in mice.

2012-01-24T17:09:50Z

Coccurello R, Brina D, Caprioli A, Conti R, Ghirardi O, Schepis F, Moles A. (2009) Psychopharmacol. 29: 6 576-83

Olanzapine (LY170053, 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5] benzodiazepine), but not the novel atypical antipsychotic ST2472 (9-piperazin-1-ylpyrrolo[2,1-b][1,3]benzothiazepine), chronic administration induces weight gain, hyperphagia, and metabolic dysregulation in mice

2012-01-24T17:06:43Z

Coccurello R, Caprioli A, Conti R, Ghirardi O, Borsini F, Carminati P, Moles A. (2008) J Pharmacol Exp Ther 326: 3 905-11

Psychosocial stress affects energy balance in mice: modulation by social status

2012-01-24T17:25:37Z

Moles A, Bartolomucci A, Garbugino L, Conti R, Caprioli A, Coccurello R, Rizzi R, Ciani B, D'Amato FR. (2006) 31: 5 623-33

TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity.

2012-01-24T17:08:54Z

Bartolomucci A, La Corte G, Possenti R, Locatelli V, Rigamonti AE, Torsello A, Bresciani E, Bulgarelli I, Rizzi R, Pavone F, D'Amato FR, Severini C, Mignogna G, Giorgi A, Schininà ME, Elia G, Brancia C, Ferri GL, Conti R, Ciani B, Pascucci T, Dell'Omo G, Muller EE, Levi A, Moles A. (2006) Proc Natl Acad Sci 103: 39 14584-9

Inhibition of hypothalamic Carnitine Palmitoyltransferase-1 decrease food intake and glucose production

2012-01-24T16:55:15Z

Obici S, Feng Z, Arduini A, Conti R and Rossetti L. (2003) Nat.Med. 9: 6 756-61

Discovery of a long-chain carbamoyl aminocarnitine derivative, a reversible carnitine palmitoyltransferase inhibitor with antiketotic and antidiabetic activity

2012-01-24T17:18:29Z

Giannessi F, Pessotto P, Tassoni E, Chiodi P, Conti R, De Angelis F, Dell'Uomo N, Catini R, Deias R, Tinti MO, Carminati P, Arduini A. J Med Chem. (2003) J Med Chem 46: 2 303-9

Reversible carnitine palmitoyltransferase inhibitors with broad chemical diversity as potential antidiabetic agents.

2012-01-24T17:20:31Z

Giannessi F, Chiodi P, Marzi M, Minetti P, Pessotto P, De Angelis F, Tassoni E, Conti R, Giorgi F, Mabilia M, Dell'Uomo N, Muck S, Tinti MO, Carminati P, Arduini A. (2001) J Med Chem 44: 15 2383-6

Seasonal pattern of glycosylation in frog liver.

2012-01-24T17:29:42Z

Leoni S, D'Alessandro A, Conti R, Marino M, Spagnuolo S, Mangiantini MT. (1991) Biosci Rep 11: 1 23-31